MREO
Mereo BioPharma Group plc
NASDAQ · Healthcare · Biotechnology · GB
$0.25
−8.16%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.01
- Revenue estimate
- $863.8K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.01
- EPS estimate
- -$0.01
- Revenue actual
- —
- Revenue estimate
- $3.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -25.0%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $2.00
- PT range
- $1.00 – $3.00
- Analysts
- 3
2 Buy0 Hold1 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026